Specialty code 183500000X · Holyoke, MA
NPI
1932754793
Since 2019
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
230 Maple St
Holyoke, MA, 01040
Phone (413) 420-6207
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$836K
2,015 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Alyssa Puia prescribed most often to Medicare patients was Jardiance (Empagliflozin), with 257 prescriptions and refills. In total Alyssa Puia wrote 2,015 Medicare prescriptions that cost $836K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-08-07.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Jardiance Empagliflozin | 257 | 267 | 37 | $159K |
| Trulicity Dulaglutide | 219 | 219 | 48 | $206K |
| Ozempic Semaglutide | 139 | 145 | 26 | $128K |
| Atorvastatin Calcium Generic | 114 | 205 | 25 | $1,036 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 100 | 181 | 30 | $9,582 |
| Metformin Hcl Generic | 90 | 160 | 23 | $757 |
| Tresiba Flextouch U-200 Insulin Degludec | 90 | 136 | 18 | $68K |
| Novolog Flexpen Insulin Aspart | 70 | 108 | 18 | $9,870 |
| Synjardy Xr Empagliflozin/Metformin Hcl | 58 | 69 | 12 | $40K |
| Tresiba Flextouch U-100 Insulin Degludec | 53 | 119 | 13 | $23K |
| Synjardy Empagliflozin/Metformin Hcl | 52 | 58 | Under 11 | $34K |
| Glipizide Generic | 49 | 59 | 12 | $462 |
| Amlodipine Besylate Generic | 46 | 80 | 13 | $320 |
| Pentips Pen Needle Pen Needle, Diabetic | 43 | 103 | 22 | $1,982 |
| Alcohol Prep Pads Alcohol Antiseptic Pads | 41 | 46 | Under 11 | $360 |
Brand drugs: 1,272 claims; generic drugs: 584 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Alyssa Puia were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.